CN1964744B - 基于包含两亲性嵌段共聚物和聚乳酸衍生物的聚合物药物载体的生物活性剂传递系统 - Google Patents
基于包含两亲性嵌段共聚物和聚乳酸衍生物的聚合物药物载体的生物活性剂传递系统 Download PDFInfo
- Publication number
- CN1964744B CN1964744B CN200580018124.1A CN200580018124A CN1964744B CN 1964744 B CN1964744 B CN 1964744B CN 200580018124 A CN200580018124 A CN 200580018124A CN 1964744 B CN1964744 B CN 1964744B
- Authority
- CN
- China
- Prior art keywords
- polymer
- compositions
- bioactivator
- group
- polylactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/912—Polymers modified by chemical after-treatment derived from hydroxycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G2261/00—Macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain of the macromolecule
- C08G2261/10—Definition of the polymer structure
- C08G2261/12—Copolymers
- C08G2261/126—Copolymers block
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L101/00—Compositions of unspecified macromolecular compounds
- C08L101/02—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
- C08L101/06—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L53/00—Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L87/00—Compositions of unspecified macromolecular compounds, obtained otherwise than by polymerisation reactions only involving unsaturated carbon-to-carbon bonds
- C08L87/005—Block or graft polymers not provided for in groups C08L1/00 - C08L85/04
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
Description
药物 | 两亲性嵌段共聚物 | 可生物降解的聚酯 | 包封率(%) | 粒径(nm) | |
初始重量 | 10mg | 810mg | 180mg | - | - |
组合物1 | 多柔比星 | mPEG-PLA-Toco | PLMA-COONa | 98 | 32 |
组合物2 | 多柔比星 | mPEG-PLGA-Toco | PLMA-COONa | 97 | 28 |
组合物3 | 多柔比星 | mPEG-PCL-Toco | 3arm-PLA-COOK | 95 | 41 |
组合物4 | 多柔比星 | Toco-PLA-PEO-PLA-Toco | 4arm-PLA-COONa | 95 | 57 |
组合物5 | 多柔比星 | mPEG-PLA-Chol | PLMA-COONa | 96 | 35 |
组合物6 | 表柔比星 | mPEG-PLA-Toco | PLMA-COONa | 97 | 38 |
组合物7 | 紫杉醇 | mPEG-PLA-Toco | PLA-COONa | 99 | 29 |
组合物8 | 紫杉醇 | mPEG-PLGA-Toco | PLMA-COONa | 101 | 30 |
组合物9 | 紫杉醇 | mPEG-PLA-Toco | PLMA-COONa | 100 | 34 |
组合物10 | 紫杉醇 | mPEG-PLA-Chol | PLMA-COONa | 99 | 34 |
Claims (16)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56894504P | 2004-05-06 | 2004-05-06 | |
US60/568,945 | 2004-05-06 | ||
PCT/KR2005/001330 WO2005107813A1 (en) | 2004-05-06 | 2005-05-06 | Delivery system for bioactive agents on the basis of a polymeric drug carrier comprising an amphiphilic block polymer and a polylacticacid derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1964744A CN1964744A (zh) | 2007-05-16 |
CN1964744B true CN1964744B (zh) | 2015-06-17 |
Family
ID=35320048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200580018124.1A Active CN1964744B (zh) | 2004-05-06 | 2005-05-06 | 基于包含两亲性嵌段共聚物和聚乳酸衍生物的聚合物药物载体的生物活性剂传递系统 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080260850A1 (zh) |
EP (1) | EP1742665B1 (zh) |
JP (1) | JP4885846B2 (zh) |
KR (1) | KR100829799B1 (zh) |
CN (1) | CN1964744B (zh) |
AT (1) | ATE531391T1 (zh) |
AU (1) | AU2005239948B9 (zh) |
CA (1) | CA2564719C (zh) |
ES (1) | ES2375715T3 (zh) |
MX (1) | MXPA06012431A (zh) |
NZ (1) | NZ550856A (zh) |
WO (1) | WO2005107813A1 (zh) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8007775B2 (en) | 2004-12-30 | 2011-08-30 | Advanced Cardiovascular Systems, Inc. | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same |
US20070015689A1 (en) * | 2005-06-23 | 2007-01-18 | Alza Corporation | Complexation of metal ions with polypeptides |
KR100858508B1 (ko) | 2005-12-23 | 2008-09-12 | 주식회사 삼양사 | 아졸계 항진균제를 포함하는 조성물 및 그의 제조방법 |
US8916206B2 (en) * | 2005-12-26 | 2014-12-23 | Ltt Bio-Pharma Co., Ltd. | Nanoparticles containing water-soluble non-peptide low-molecular weight drug |
CN101500546A (zh) * | 2006-08-17 | 2009-08-05 | 诺瓦提斯公司 | 纳米粒组合物 |
CA2716082A1 (en) * | 2008-03-04 | 2009-02-23 | F. Hoffmann-La Roche Ag | Process for preparing concentrated aqueous micellar solutions |
US8652506B2 (en) * | 2008-06-05 | 2014-02-18 | Boston Scientific Scimed, Inc. | Bio-degradable block co-polymers for controlled release |
US20110104056A1 (en) * | 2008-06-05 | 2011-05-05 | Isao Hara | Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |
CN102300556B (zh) * | 2008-12-26 | 2015-04-29 | 株式会社三养生物制药 | 含有阴离子药物的药物组合物及其制备方法 |
US10292932B2 (en) * | 2008-12-26 | 2019-05-21 | Samyang Biopharmaceuticals Corporation | Polymeric micelle particle comprising anionic drugs and method of preparing the same |
WO2010114768A1 (en) * | 2009-03-30 | 2010-10-07 | Cerulean Pharma Inc. | Polymer-epothilone conjugates, particles, compositions, and related methods of use |
MX2011010390A (es) * | 2009-03-30 | 2011-12-14 | Cerulean Pharma Inc | Conjugados, particulas, composiciones de agentes polimericos y metodos relacionados de uso. |
KR101224004B1 (ko) * | 2009-12-29 | 2013-01-22 | 주식회사 삼양바이오팜 | 단백질, 폴리펩타이드 또는 펩타이드 약물 전달용 고분자 및 그 제조방법, 및 단백질, 폴리펩타이드 또는 펩타이드 약물의 서방형 조성물 및 그 제조 방법 |
KR101296326B1 (ko) * | 2009-12-30 | 2013-08-14 | 주식회사 삼양바이오팜 | 폴리락트산을 포함하는 음이온성 약물 전달용 조성물 및 그 제조 방법 |
KR101267813B1 (ko) | 2009-12-30 | 2013-06-04 | 주식회사 삼양바이오팜 | 향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물 |
KR101424163B1 (ko) * | 2010-12-24 | 2014-08-01 | 주식회사 삼양바이오팜 | 수난용성 약물 함유 서방성 마이크로입자 및 그 제조방법 |
KR101411349B1 (ko) * | 2010-12-24 | 2014-06-25 | 주식회사 삼양바이오팜 | 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물 |
US8834861B2 (en) | 2011-03-10 | 2014-09-16 | International Business Machines Corporation | Polycarbonates for delivery of drugs and methods of preparation thereof |
CN103120644B (zh) * | 2011-11-17 | 2016-12-21 | 山东绿叶制药有限公司 | 生物功能性蛋白大分子的两亲嵌段共聚物胶束及其制备和应用 |
US9439856B2 (en) | 2012-04-04 | 2016-09-13 | Samyang Biopharmaceuticals Corporation | Method of preparing composition for delivering an anionic drug |
ES2433248B1 (es) * | 2012-05-07 | 2015-03-10 | Consejo Superior Investigacion | Copolimeros anfifilicos portadores de alfa-tocoferol con propiedades antitumorales |
JP6487051B2 (ja) * | 2014-12-30 | 2019-03-20 | サムヤン バイオファーマシューティカルズ コーポレイションSamyang Biopharmaceuticals Corporation | ポリマーナノ粒子の凍結乾燥物、及びその製造方法 |
MX2018003096A (es) * | 2015-09-15 | 2018-05-11 | Samyang Biopharmaceuticals | Composicion farmaceutica que contiene farmaco anionico, y metodo de preparacion para la misma. |
CN108366964B (zh) * | 2015-12-18 | 2022-04-08 | 三养控股公司 | 制备含阴离子药物的聚合物胶束的方法 |
KR101949507B1 (ko) * | 2016-11-09 | 2019-02-18 | 주식회사 삼양바이오팜 | Kras를 표적으로 하는 핵산 함유 약제학적 조성물 및 그 제조방법 |
KR101971672B1 (ko) | 2016-11-18 | 2019-04-23 | 주식회사 삼양바이오팜 | 화학색전용 에멀전 조성물 및 그의 제조방법 |
JP6796205B2 (ja) * | 2016-12-14 | 2020-12-02 | サムヤン バイオファーマシューティカルズ コーポレイションSamyang Biopharmaceuticals Corporation | ミセル安定性が向上した両親媒性ブロック共重合体組成物及びそれを含む医薬組成物 |
KR102259513B1 (ko) * | 2017-11-16 | 2021-06-02 | 주식회사 삼양홀딩스 | 음이온성 약물 함유 약제학적 조성물의 동결건조 조성물 및 방법 |
CA3108053C (en) * | 2018-08-07 | 2024-05-14 | Samyang Biopharmaceuticals Corporation | Polymer nanoparticle composition for delivering virus, and preparation method therefor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1352568A (zh) * | 1999-04-02 | 2002-06-05 | 加拿大国家研究局 | 生物活性亲脂性化合物的水溶性组合物 |
WO2003059382A2 (en) * | 2001-12-28 | 2003-07-24 | Supratek Pharma Inc. | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
CN1780865A (zh) * | 2003-10-10 | 2006-05-31 | 株式会社三养社 | 两亲嵌段共聚物以及包含它的用于给药的聚合组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07122099B2 (ja) * | 1991-01-10 | 1995-12-25 | 川崎製鉄株式会社 | 密着性、耐泡・黒点欠陥性に優れたほうろう用鋼板の製造方法 |
KR0180334B1 (ko) * | 1995-09-21 | 1999-03-20 | 김윤 | 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법 |
US5932539A (en) * | 1996-10-15 | 1999-08-03 | The Board Of Trustees Of The University Of Illinois | Biodegradable polymer matrix for tissue repair |
US8778322B2 (en) * | 2001-10-18 | 2014-07-15 | Samyang Biopharmaceuticals Corporation | pH responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
EP1448707B1 (en) * | 2001-10-18 | 2007-08-22 | Samyang Corporation | Polymeric micelle composition with improved stability |
US7311901B2 (en) * | 2003-10-10 | 2007-12-25 | Samyang Corporation | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery |
AU2003272127A1 (en) * | 2003-10-24 | 2005-05-11 | Samyang Corporation | Polymeric composition for drug delivery |
-
2005
- 2005-05-06 AT AT05739818T patent/ATE531391T1/de active
- 2005-05-06 KR KR1020067021846A patent/KR100829799B1/ko active IP Right Grant
- 2005-05-06 MX MXPA06012431A patent/MXPA06012431A/es active IP Right Grant
- 2005-05-06 CA CA2564719A patent/CA2564719C/en active Active
- 2005-05-06 CN CN200580018124.1A patent/CN1964744B/zh active Active
- 2005-05-06 AU AU2005239948A patent/AU2005239948B9/en not_active Ceased
- 2005-05-06 US US11/568,313 patent/US20080260850A1/en not_active Abandoned
- 2005-05-06 ES ES05739818T patent/ES2375715T3/es active Active
- 2005-05-06 WO PCT/KR2005/001330 patent/WO2005107813A1/en active Application Filing
- 2005-05-06 JP JP2007511292A patent/JP4885846B2/ja active Active
- 2005-05-06 NZ NZ550856A patent/NZ550856A/en not_active IP Right Cessation
- 2005-05-06 EP EP05739818A patent/EP1742665B1/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1352568A (zh) * | 1999-04-02 | 2002-06-05 | 加拿大国家研究局 | 生物活性亲脂性化合物的水溶性组合物 |
WO2003059382A2 (en) * | 2001-12-28 | 2003-07-24 | Supratek Pharma Inc. | Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression |
CN1780865A (zh) * | 2003-10-10 | 2006-05-31 | 株式会社三养社 | 两亲嵌段共聚物以及包含它的用于给药的聚合组合物 |
Also Published As
Publication number | Publication date |
---|---|
ATE531391T1 (de) | 2011-11-15 |
CN1964744A (zh) | 2007-05-16 |
AU2005239948A1 (en) | 2005-11-17 |
CA2564719C (en) | 2011-11-01 |
EP1742665A1 (en) | 2007-01-17 |
WO2005107813A1 (en) | 2005-11-17 |
ES2375715T3 (es) | 2012-03-05 |
KR100829799B1 (ko) | 2008-05-16 |
JP2007536219A (ja) | 2007-12-13 |
CA2564719A1 (en) | 2005-11-17 |
US20080260850A1 (en) | 2008-10-23 |
EP1742665B1 (en) | 2011-11-02 |
AU2005239948B2 (en) | 2008-09-18 |
JP4885846B2 (ja) | 2012-02-29 |
KR20070002063A (ko) | 2007-01-04 |
MXPA06012431A (es) | 2007-01-17 |
NZ550856A (en) | 2010-11-26 |
AU2005239948B9 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1964744B (zh) | 基于包含两亲性嵌段共聚物和聚乳酸衍生物的聚合物药物载体的生物活性剂传递系统 | |
Chang et al. | Fast degradable polycaprolactone for drug delivery | |
Yu et al. | The anti-tumor efficacy of curcumin when delivered by size/charge-changing multistage polymeric micelles based on amphiphilic poly (β-amino ester) derivates | |
US7311901B2 (en) | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery | |
ES2292827T3 (es) | Composicion micelar polimerica con estabilidad mejorada. | |
Bonacucina et al. | Thermosensitive self-assembling block copolymers as drug delivery systems | |
Liu et al. | Biocompatible and biodegradable polymersomes for pH-triggered drug release | |
CN101787119A (zh) | 一种具有肿瘤组织pH响应性的聚合物及其胶束 | |
Wu et al. | In vitro drug release and biological evaluation of biomimetic polymeric micelles self-assembled from amphiphilic deoxycholic acid–phosphorylcholine–chitosan conjugate | |
EP1670838B1 (en) | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery | |
Malhotra et al. | Polymer topology driven enzymatic biodegradation in polycaprolactone block and random copolymer architectures for drug delivery to cancer cells | |
CN106474060B (zh) | 具有pH和还原双重敏感的两亲三嵌段共聚物及其制备和应用 | |
CN1961962B (zh) | 两亲性三嵌段共聚物-紫杉醇键合药及其合成方法 | |
JP2019501261A (ja) | 生分解性両親媒性ポリマー、それにより製造されるポリマーベシクル、及び肺がん標的治療薬の製造における使用 | |
CN104116710A (zh) | 靶向肿瘤的pH敏感聚合物胶束组合物 | |
Xu et al. | Synthesis, self-assembly, and drug delivery characteristics of poly (methyl caprolactone-co-caprolactone)-b-poly (ethylene oxide) copolymers with variable compositions of hydrophobic blocks: combining chemistry and microfluidic processing for polymeric nanomedicines | |
CN104116709A (zh) | 靶向肿瘤的抗肿瘤耐药的pH敏感聚合物胶束组合物 | |
Wang et al. | Novel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridonin | |
CN101683272A (zh) | 超声敏感载药纳米泡 | |
CN104116711A (zh) | 抗肿瘤耐药的pH敏感聚合物胶束组合物 | |
WO2016172042A1 (en) | Polymer systems and their applications in diagnostics and drug delivery | |
Feng et al. | Y-shaped folic acid-conjugated PEG-PCL copolymeric micelles for delivery of curcumin | |
CN100434120C (zh) | 两亲性荧光靶向纳米胶束及其制备方法 | |
CN100471886C (zh) | 两亲嵌段共聚物以及包含它的用于给药的聚合组合物 | |
CN101824142A (zh) | 一种生物可降解聚乙二醇酯及其制备方法和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SAMYANG CORPORATION Free format text: FORMER OWNER: SAM YANG CO., LTD. Effective date: 20121102 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20121102 Address after: Seoul, South Kerean Applicant after: Samyang Biopharmaceuticals Corporation Address before: Seoul, South Kerean Applicant before: SAMYANG Corporation |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210811 Address after: Seoul City, Korea Patentee after: Sanyang holding Co. Address before: Seoul, South Kerean Patentee before: SAMYANG BIOPHARMACEUTICALS Corp. |